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Abstract
Background: The Medium-chain Dehydrogenases/Reductases (MDR) form a protein superfamily whose size and
complexity defeats traditional means of subclassification; it currently has over 15000 members in the databases, the
pairwise sequence identity is typically around 25%, there are members from all kingdoms of life, the chain-lengths
vary as does the oligomericity, and the members are partaking in a multitude of biological processes. There are
profile hidden Markov models (HMMs) available for detecting MDR superfamily members, but none for
determining which MDR family each protein belongs to. The current torrential influx of new sequence data
enables elucidation of more and more protein families, and at an increasingly fine granularity. However, gathering
good quality training data usually requires manual attention by experts and has therefore been the rate limiting
step for expanding the number of available models.
Results: We have developed an automated algorithm for HMM refinement that produces stable and reliable
models for protein families. This algorithm uses relationships found in data to generate confident seed sets. Using
this algorithm we have produced HMMs for 86 distinct MDR families and 34 of their subfamilies which can be
used in automated annotation of new sequences. We find that MDR forms with 2 Zn
2+ ions in general are
dehydrogenases, while MDR forms with no Zn
2+ in general are reductases. Furthermore, in Bacteria MDRs without
Zn
2+ are more frequent than those with Zn
2+, while the opposite is true for eukaryotic MDRs, indicating that Zn
2+
has been recruited into the MDR superfamily after the initial life kingdom separations. We have also developed a
web site http://mdr-enzymes.org that provides textual and numeric search against various characterised MDR
family properties, as well as sequence scan functions for reliable classification of novel MDR sequences.
Conclusions: Our method of refinement can be readily applied to create stable and reliable HMMs for both MDR
and other protein families, and to confidently subdivide large and complex protein superfamilies. HMMs created
using this algorithm correspond to evolutionary entities, making resolution of overlapping models straightforward.
The implementation and support scripts for running the algorithm on computer clusters are available as open
source software, and the database files underlying the web site are freely downloadable. The web site also makes
our findings directly useful also for non-bioinformaticians.
Background
The superfamily of MDR proteins is formed by quinone
reductases, leukotriene B4 dehydrogenases, polyol dehy-
drogenases, Zn
2+ dependent ADHs (alcohol dehydro-
genases), and many more families. A recent estimate
places the total number of MDR families close to 500,
with less than 30% sequence identity between the
families [1]. Numbers of known superfamily members
have grown considerably in recent years, and it currently
has over 15000 members in the UniProtKB database [2],
which is more than an order of magnitude higher than
the number six years ago [3]. Disregarding species var-
iants, there is considerable multiplicity, with at least 25
MDR forms in the human, excluding close homologues.
R o u g h l yh a l fo ft h eM D Rp r o t e i n sc a nb eg r o u p e di n t o
large clusters with 100’s of members, while about 1000
forms belong to small clusters with 10 or fewer
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spread resembling the complexity of the SDR (short-
chain dehydrogenase/reductase) family [4]. This is a new
characteristic of the MDR family, not detectable until
now when data from many large-scale genome projects
exist.
The first characterised member was the class I type of
mammalian alcohol dehydrogenase, for which the pri-
mary structure was reported in 1970 [5]. Subsequently
detected MDR members included sorbitol dehydrogen-
ase [6], a crystallin, metabolic enzymes and a synaptic
protein [7]. The latter report also coined the term MDR
[7]. This distinction from SDR, with its typically smaller
subunits (~250-residue subunits) and no metal depen-
dence, was known [8], but initially named as a long-
chain form. The split into separate protein types was
detected already in the 1970’s when the first data on
Drosophila ADH showed sequence patterns separate
from those of the Zn
2+ dependent ADHs [9].
The MDR proteins typically consist of two domains,
where the C-terminal domain is coenzyme-binding with
the ubiquitous Rossmann fold [10] of an often six-
stranded parallel b-sheet sandwiched between a-helices
on each side. The N-terminal domain is substrate binding
with a core of antiparallel b-strands and surface-
positioned a-helices, showing distant homology with the
GroES structure [11]. The domains are separated by a
cleft containing a deep pocket which accommodates the
active site. The MDR proteins generally form homodi-
mers, but some members are active as monomers like the
MTD family [12,13], or tetramers like the PDH family.
The metal dependence also varies between families.
W h i l em a n yM D Rf a m i l i e sb i n do n ec a t a l y t i ca n do n e
structural Zn
2+ per subunit [1], many sorbitol dehydro-
genases in the PDH family bind only the catalytic Zn
2+
[6,14,15] (cf. MDR005 below), and the prostaglandin
reductases in the PTGR family bind no Zn
2+ [16].
In a recent review [1] we showed that the size and
complexity of the MDR superfamily challenges tradi-
tional means of subclassification such as linear sequence
pattern matching, but we were able to present models
for automated classification of a number of the MDR
families.
Hidden Markov models (HMMs) are statistical descrip-
tions of the characteristic sequence variations within a
protein family, and have been put to good use in protein
classification since over a decade [17]. An alignment
between a sequence and an HMM gives a statistical mea-
sure of the quality of the match, which can be used to
reliably determine whether or not the sequence is a
member of the modelled family. Collections of HMMs
such as the PfamA and Interpro databases [18-20] there-
fore greatly facilitate the annotation of new sequences.
Large families can also be subclassified using HMMs,
which was recently demonstrated for the SDR superfam-
ily of short-chain dehydrogenases/reductases [21].
HMMs are products of machine learning and the qual-
ity of the training data is therefore crucial for the reliabil-
ity of resulting models. High quality training data should
well describe the diversity within the family, without
overgeneralisation that would result in overprediction.
Assembling good quality training data usually requires
hands-on work by experts in the field and has therefore
been the rate limiting step for expanding the number of
available protein family models. These principles also
apply when HMMs are used for subclassification.
So far, there are HMMs available for detecting mem-
bership of the MDR superfamily, but no HMMs are
available for the individual families. In this work, we
present a method for automated HMM refinement that
produces stable and reliable HMMs. We have used this
method to produce HMMs for 86 distinct MDR families
and 34 of their subfamilies. We have also characterised
these families based on conservation, NAD(P) and Zn
2+
cofactor preference, and species distribution.
Results and Discussion
MDR families
Hidden Markov models (HMMs) were developed for
protein families within the superfamily of MDR. This is
necessary since the MDR superfamily now is found to
be very large and divergent with over 15000 members
and many different enzyme activities. In Pfam [20],
there are only two MDR-HMMs available - one for the
N-terminal domain [PfamA:PF08240] and one for the
C-terminal domain [PfamA:PF00107]. The aim was that
each HMM now developed should be specific for each
MDR family. Therefore a method was developed to
automatically derive stable HMMs using an iterative
procedure.
Here, initial HMMs were built from multiple sequence
alignments (MSAs) of disjoint MDR sequence clusters
sharing more than 40% residue identities in pairwise
comparisons. These HMMs were used to search the
UniProtKB database finding additional members, which
were then incorporated into their respective training
sets to produce refined HMMs. After multiple iterations,
typically below 8, the refined HMMs no longer detected
any new members in the database. The stability of the
model was assessed using jackknifing (cf. Methods), and
any unstable HMMs were again subjected to iterative
refinement once the spurious sequence(s) had been
removed. After 4 reiterations, all except 2 HMMs were
deemed stable and reliable (cf. Methods).
Using this iterative procedure, a total of 86 HMMs
were developed, which are listed in Table 1. We
assigned identifiers to these MDR families from
MDR001 through MDR086 based on enumeration by
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ID Name Size Swiss-Prot PCID Avg (StdDev) Eukaryotic Bacterial Archaeal
MDR001 ADH 2217 116 51.24 (19.02) 1315 (59.3%) 895 (40.4%) 6 (0.3%)
MDR002 PTGR 774 17 42.46 (9.64) 253 (32.7%) 518 (66.9%) 3 (0.4%)
MDR003 FAS 706 11 39.07 (9.88) 288 (40.8%) 418 (59.2%) 0 (0.0%)
MDR004 QORX 486 1 47.47 (10.07) 69 (14.2%) 417 (85.8%) 0 (0.0%)
MDR005 PDH 328 18 45.59 (11.81) 181 (55.2%) 146 (44.5%) 1 (0.3%)
MDR006 ZADH2 56 4 51.49 (15.19) 51 (91.1%) 5 (8.9%) 0 (0.0%)
MDR007 MECR 51 9 54.60 (13.15) 51 (100.0%) 0 (0.0%) 0 (0.0%)
MDR008 VAT1 50 6 60.49 (19.60) 48 (96.0%) 2 (4.0%) 0 (0.0%)
MDR009 vertQOR 22 8 70.12 (10.34) 21 (95.5%) 1 (4.5%) 0 (0.0%)
MDR010 CAD 661 32 49.08 (10.02) 329 (49.8%) 330 (49.9%) 2 (0.3%)
MDR011 bpQOR 575 5 47.93 (11.86) 66 (11.5%) 509 (88.5%) 0 (0.0%)
MDR012 YHDH 481 2 53.92 (11.43) 1 (0.2%) 477 (99.2%) 0 (0.0%)
MDR013 FDH 375 4 47.16 (12.56) 29 (7.7%) 346 (92.3%) 0 (0.0%)
MDR014 TDH 351 126 69.40 (16.11) 1 (0.3%) 343 (97.7%) 7 (2.0%)
MDR015 QORL2 319 4 45.25 (8.76) 38 (11.9%) 281 (88.1%) 0 (0.0%)
MDR016 bADH 313 17 60.72 (15.62) 1 (0.3%) 312 (99.7%) 0 (0.0%)
MDR017 279 8 51.97 (8.93) 2 (0.7%) 277 (99.3%) 0 (0.0%)
MDR018 194 1 47.22 (10.60) 48 (24.7%) 146 (75.3%) 0 (0.0%)
MDR019 136 0 60.51 (12.37) 18 (13.2%) 118 (86.8%) 0 (0.0%)
MDR020 yADH 128 22 63.56 (12.11) 128 (100.0%) 0 (0.0%) 0 (0.0%)
MDR021 YJGB 122 1 69.98 (20.96) 2 (1.6%) 120 (98.4%) 0 (0.0%)
MDR022 giFDH 122 2 63.32 (18.53) 5 (4.1%) 111 (91.0%) 6 (4.9%)
MDR023 72 5 52.93 (17.12) 10 (13.9%) 56 (77.8%) 6 (8.3%)
MDR024 40 0 52.66 (11.72) 7 (17.5%) 32 (80.0%) 1 (2.5%)
MDR025 yPDH 34 0 65.44 (13.11) 34 (100.0%) 0 (0.0%) 0 (0.0%)
MDR026 yDH 34 0 60.48 (13.13) 34 (100.0%) 0 (0.0%) 0 (0.0%)
MDR027 QORH 34 2 60.28 (10.85) 34 (100.0%) 0 (0.0%) 0 (0.0%)
MDR028 29 0 55.36 (9.11) 1 (3.4%) 28 (96.6%) 0 (0.0%)
MDR029 yADH2 29 1 59.02 (15.24) 29 (100.0%) 0 (0.0%) 0 (0.0%)
MDR030 dFAS 28 0 57.51 (16.34) 28 (100.0%) 0 (0.0%) 0 (0.0%)
MDR031 yDH2 28 0 53.43 (12.87) 28 (100.0%) 0 (0.0%) 0 (0.0%)
MDR032 bADH2 26 0 69.59 (17.08) 1 (3.8%) 25 (96.2%) 0 (0.0%)
MDR033 yBDH 23 2 54.51 (12.62) 23 (100.0%) 0 (0.0%) 0 (0.0%)
MDR034 23 0 54.57 (14.09) 13 (56.5%) 10 (43.5%) 0 (0.0%)
MDR035 22 0 47.17 (10.55) 22 (100.0%) 0 (0.0%) 0 (0.0%)
MDR036 bADH3 21 4 50.26 (15.82) 1 (4.8%) 12 (57.1%) 8 (38.1%)
MDR037 20 0 66.14 (13.09) 20 (100.0%) 0 (0.0%) 0 (0.0%)
MDR038 20 0 74.56 (12.47) 20 (100.0%) 0 (0.0%) 0 (0.0%)
MDR039 bADH4 150 0 58.99 (10.83) 0 (0.0%) 150 (100.0%) 0 (0.0%)
MDR040 SORE 117 2 61.62 (21.91) 0 (0.0%) 117 (100.0%) 0 (0.0%)
MDR041 BurkDH 114 0 63.89 (15.74) 0 (0.0%) 114 (100.0%) 0 (0.0%)
MDR042 YJJN 114 1 57.50 (18.31) 0 (0.0%) 114 (100.0%) 0 (0.0%)
MDR043 IDND 96 1 55.99 (17.90) 0 (0.0%) 96 (100.0%) 0 (0.0%)
MDR044 96 0 54.24 (13.62) 0 (0.0%) 92 (95.8%) 4 (4.2%)
MDR045 89 0 56.57 (14.09) 0 (0.0%) 89 (100.0%) 0 (0.0%)
MDR046 RSPB 78 1 72.88 (16.80) 0 (0.0%) 78 (100.0%) 0 (0.0%)
MDR047 72 0 58.49 (18.18) 0 (0.0%) 72 (100.0%) 0 (0.0%)
MDR048 GATD 71 2 83.33 (14.94) 0 (0.0%) 71 (100.0%) 0 (0.0%)
MDR049 69 0 54.89 (14.55) 0 (0.0%) 69 (100.0%) 0 (0.0%)
MDR050 CCR 67 0 72.88 (15.83) 0 (0.0%) 67 (100.0%) 0 (0.0%)
MDR051 TARJ 63 1 60.87 (21.70) 0 (0.0%) 62 (98.4%) 1 (1.6%)
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tion, starting with families having at least one human
representative and then families having at least one
eukaryotic representative, and ending with the purely
prokaryotic families. These HMMs encompass a total of
11579 members, thus representing just over 76% of all
MDR superfamily members. The remaining members
form families with too few members to establish HMMs
with sufficiently strong predictive power. The 86 HMMs
now presented will be helpful in assignment of functions
for MDR members for which the enzymatic function is
not known, and they will also help to increase the level
of granularity attainable in reliable automatic functional
assignment of new sequences. This is of course crucial
for understanding relationships in new collected
sequence data.
As can be seen in Figure 1, the number of members
varies from 20 to 2217 among these HMMs, with an
average number around 135 sequences. The average
sequence identity within the individual families varies
from 39.1% to 93.7%, with an average-of-averages of
61% and a sample standard deviation of 11.3 percent
units. The largest MDR family is that of ADH
(MDR001) with presently well over 2000 members.
A m o n gt h et o p1 0i ns i z ew ea l s of i n dP T G R
(MDR002), FAS (MDR003), CAD (MDR010), QOR
Table 1 Properties of MDR families (Continued)
MDR052 YCJQ 48 2 91.08 (10.57) 0 (0.0%) 48 (100.0%) 0 (0.0%)
MDR053 48 0 50.84 (14.22) 0 (0.0%) 48 (100.0%) 0 (0.0%)
MDR054 YDJL 46 1 93.70 (12.44) 0 (0.0%) 46 (100.0%) 0 (0.0%)
MDR055 44 0 63.84 (10.29) 0 (0.0%) 44 (100.0%) 0 (0.0%)
MDR056 44 0 63.41 (20.64) 0 (0.0%) 44 (100.0%) 0 (0.0%)
MDR057 BCHC 43 2 61.89 (8.07) 0 (0.0%) 43 (100.0%) 0 (0.0%)
MDR058 43 0 76.53 (11.52) 0 (0.0%) 43 (100.0%) 0 (0.0%)
MDR059 42 0 56.97 (9.37) 0 (0.0%) 42 (100.0%) 0 (0.0%)
MDR060 YPHC 42 1 84.08 (22.01) 0 (0.0%) 42 (100.0%) 0 (0.0%)
MDR061 bBDH 40 0 63.33 (22.56) 0 (0.0%) 40 (100.0%) 0 (0.0%)
MDR062 CCR2 40 0 73.01 (14.76) 0 (0.0%) 40 (100.0%) 0 (0.0%)
MDR063 38 0 58.21 (20.04) 0 (0.0%) 38 (100.0%) 0 (0.0%)
MDR064 33 0 81.63 (18.31) 0 (0.0%) 33 (100.0%) 0 (0.0%)
MDR065 32 0 53.79 (11.72) 0 (0.0%) 31 (96.9%) 1 (3.1%)
MDR066 32 1 82.45 (18.25) 0 (0.0%) 32 (100.0%) 0 (0.0%)
MDR067 bQOR 32 0 73.92 (21.12) 0 (0.0%) 32 (100.0%) 0 (0.0%)
MDR068 32 0 55.05 (10.93) 0 (0.0%) 32 (100.0%) 0 (0.0%)
MDR069 32 0 54.76 (13.41) 0 (0.0%) 30 (93.8%) 2 (6.2%)
MDR070 31 0 50.14 (19.08) 0 (0.0%) 31 (100.0%) 0 (0.0%)
MDR071 31 0 52.17 (11.37) 0 (0.0%) 31 (100.0%) 0 (0.0%)
MDR072 bDHSO 31 1 65.28 (20.13) 0 (0.0%) 31 (100.0%) 0 (0.0%)
MDR073 bQOR2 31 0 81.84 (19.40) 0 (0.0%) 31 (100.0%) 0 (0.0%)
MDR074 30 0 79.07 (19.18) 0 (0.0%) 30 (100.0%) 0 (0.0%)
MDR075 29 0 82.92 (18.37) 0 (0.0%) 29 (100.0%) 0 (0.0%)
MDR076 29 0 57.41 (13.46) 0 (0.0%) 29 (100.0%) 0 (0.0%)
MDR077 28 0 58.92 (10.41) 0 (0.0%) 24 (85.7%) 4 (14.3%)
MDR078 RhobDH 25 0 55.27 (11.23) 0 (0.0%) 25 (100.0%) 0 (0.0%)
MDR079 25 0 63.69 (12.82) 0 (0.0%) 25 (100.0%) 0 (0.0%)
MDR080 bPDH 24 0 75.24 (15.12) 0 (0.0%) 24 (100.0%) 0 (0.0%)
MDR081 23 0 53.96 (19.57) 0 (0.0%) 23 (100.0%) 0 (0.0%)
MDR082 23 0 63.98 (10.48) 0 (0.0%) 23 (100.0%) 0 (0.0%)
MDR083 21 0 57.76 (20.40) 0 (0.0%) 9 (42.9%) 12 (57.1%)
MDR084 21 0 44.68 (12.83) 0 (0.0%) 21 (100.0%) 0 (0.0%)
MDR085 21 0 68.74 (15.71) 0 (0.0%) 21 (100.0%) 0 (0.0%)
MDR086 MycDH 20 0 65.99 (28.08) 0 (0.0%) 20 (100.0%) 0 (0.0%)
This table shows properties of the MDR families for which we have derived HMMs, including its assigned name (if any), size, number of members in the Swiss-
Prot database, average percent pairwise sequence identities in the family (and sample standard deviation) and distribution of members over the kingdoms of life
(and proportions). See also Additional file 2: mdr-properties for further data. Empty name fields indicate families where the function has not yet been established
for any of the members.
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Page 4 of 16(MDR011), QORX (MDR004), YHDH (MDR012), FDH
(MDR013), TDH (MDR014) and PDH (MDR005).
Numerical details on the individual MDR families are
available in Table 1, showing also the kingdom repre-
sentation for the families. Further details on conserva-
tion and cofactor preference are available in Additional
file 1: mdr-properties. The HMM database is available
as Additional file 2: mdr-pfam and the accompanying
sequence data is available in Additional file 3: mdr-
sequences. Coloured MSAs for the families are shown in
Additional file 4: mdr-figures.
Dendrogram
In order to investigate the interrelations between these
families we built a bootstrapped ClustalW neighbour-
joining dendrogram of representative sequences (Figure
2). The families are approximately equidistantly posi-
tioned in the tree and the bootstrap values (not shown)
are consistently low. The topology of the MDR family
tree is thus similar to that of its sister protein superfam-
ily, SDR. However we do see some trends in the group-
ings, as families that bind NAD and two Zn
2+ are
generally found in the upper half of the dendrogram
(largely eukaryotes) and those that bind NADP and no
Zn
2+ are generally found in the lower half of the den-
drogram (largely prokaryotes).
Some families with similar function tend to cluster
consistently in the dendrogram (shown using red dia-
monds). For example, SDH (MDR005; sorbitol, mannitol
and polyol DHs) is found together with yPDH
(MDR025; yeast polyol DHs) in 996 out of 1000 boot-
strap reconstructions of the dendrogram. Similarly, with
a bootstrap value of 949 BDH1 (MDR033; eukaryotic
butanediol DH) clusters with its bacterial sibling family
bPDH (MDR080), and in all bootstrap reconstructions
of the dendrogram the prokaryotic crotonyl CoA reduc-
tases in CCR and CCR2 cluster (MDR050 and
MDR062).
Furthermore, a few families that were previously treated
as a single family [1] are now represented by two or more
HMMs, that cluster together in a significant number of
bootstrap reconstructions. For example the tetrameric
ADHs of MDR016 (bADH, bacterial ADHs), MDR020
(yADH, yeast ADHs) and MDR029 (yADH2, yeast ADH2)
are found together in 924 cases, and were indeed pre-
viously described as a single evolutionary group under the
name TADH. Also, the mitochondrial trans-2-enoyl-CoA
reductases of MDR007 and MDR037 (previously described
as MECR) are found together in 987 cases.
Lastly, MDR024 and MDR034 cluster together in all
bootstraps reconstructions of the tree. However, not
Figure 1 Size distribution in MDR families. The bar chart shows the number of seed sequences for the 86 stable and reliable HMMs using
inclusion control strategy II, ordered by MDR family number. The number of seed sequences varies from 20 to 2217, and the average is around
137 sequences. The other strategies produce very similar size distributions.
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pairwise sequence identities of over 50%, have eukaryo-
tic and prokaryotic members, and apparently bind two
Zn
2+ ions.
Correlation with known families
In a recent MDR review [1], we highlighted 17 families
of interest, based on family size or presence of a human
member sequence. That selection of families was man-
ual, as was the refinement of their derived HMMs.
Using the current more systematic approach to subclas-
sification we see that almost all of the families high-
lighted in the review still have well-correlating
counterparts, the exceptions being the smallest families
DOIAD, QORL and RT4I (cf. Table 2). Presumably,
there is still not enough data available on these families
for meeting the minimum size requirement employed in
this study. Notably, the CAD, TAD and MECR families
were now represented by two or more HMMs (see
below). As a check for consistency, we therefore also
produced merged HMMs for these families. All of these
produced non-overlapping HMMs that became stable in
the first or second iteration, demonstrating our algo-
rithm’s capability of finding evolutionary supersets for
coherent and related subsets. Conversely, the MCAS
and ACR families are now incorporated into a single,
much larger HMM. This may be desirable from a func-
tional perspective since both MCAS and ACR have
functions related to fatty acid synthesis. Knowledge on
Figure 2 Dendrogram of the 86 MDR families. A ClustalW neighbour-joining dendrogram of representative sequences from the 86 MDR
families. Blue lines indicate families with at least one human member and green lines indicate families with at least one eukaryotic member. The
families with members that bind NAD and two Zn
2+ are generally found in the upper half of the dendrogram (indicated with a yellow frame)
while those with members that bind NADP and no Zn
2+ are almost exclusively found in the lower half (indicated with a purple frame).
Exceptions to the NAD/NADP cofactor preference indicated within the frames are highlighted by labels in the opposing colour. Exceptions to
the number of bound Zn
2+ indicated within the frames are shown using bullet symbols. Two filled bullets correspond to 2 Zn
2+, one filled bullet
to 1 Zn
2+, and an unfilled bullet to 0 Zn
2+. Half-bullet symbols are used to indicate cases where the ligands for one of the Zn
2+ are conserved
only among part of the family members. Although bootstrap values are consistently low (not shown), six branch points were observed in over
900 of the 1000 bootstrap reconstructions of the dendrogram (indicated using red diamonds).
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Page 6 of 16these families have now grown to roughly twice that at
the time of our review, with the exception of DOIAD,
QORL, RT4I (the three smallest families mentioned
above), and QOR (fifth smallest family).
Zn
2+ content
The MDR members have 0, 1 or 2 Zn
2+ ions per subunit.
One Zn
2+ ion is located at the catalytic site and is desig-
nated catalytic Zn
2+,w h i l eo n eZ n
2+ ion is stabilising a
loop encompassing residues 94-117 (human ADH1beta
numbering) and is designated structural Zn
2+.O ft h e8 6
MDR families now characterised, we find that 35 of the
MDR families seemingly have 2 Zn
2+, i.e. both the cataly-
tic and structural Zn
2+, 7 MDR families have 1 Zn
2+,
while 38 MDR families seem to have no Zn
2+.A m o n g
Bacteria, over half (54%, Table 3) are MDR forms without
Zn
2+, while among Eukaryota, 66% of the MDR forms
have 2 Zn
2+. This finding indicates that the Zn
2+ have
been recruited early but not initially upon the MDR
superfamily formation.
Six MDR families (MDR005, MDR014, MDR033,
MDR047, MDR061 and MDR077) consist of members
where some have 2 Zn
2+ while other members only have 1
Zn
2+, where typically one or more of the ligands for the
structural Zn
2+ have been lost. This variable Zn
2+ content
within the same MDR family has not been described
before. Furthermore, in two MDR families (MDR058 and
MDR083) the members seem to retain the structural Zn
2+
but not the catalytic Zn
2+, which is clearly different from
the typical pattern within the MDR superfamily. This also
applies to part of the family MDR033 (cf. above).
Coenzyme preference
We have also looked at the coenzyme specificity as
judged from available data or the presence of NAD- or
NADP-specific ligands. A total of 44 families use NAD
as cofactor, while 40 families use NADP. In nearly all
f a m i l i e st h ec o e n z y m ep r e f e r e n c es e e m st ob ec o n s t a n t
for all members, but in one family (MDR023, cf. below)
half of the members bind NAD (36/72), while the other
half prefers NADP.
Correlation between Zn
2+ content and coenzyme preference
With many MDR families now characterised, we can
distinguish novel patterns. There is a clear correlation
between Zn
2+ content and coenzyme preference. Most
of the MDR families with 2 Zn
2+ prefer NAD as cofac-
tor and are thereby generally acting as dehydrogenases.
Of the 35 families with 2 Zn
2+, 30 exhibit preference for
NAD. Similarly, there is a correlation between no Zn
2+
content and utilisation of NADP as cofactor. Of the 38
families with no Zn
2+, 34 exhibit preference for NADP
and are consequently largely reductases.
As exceptions from these general patterns we find four
families, YJGB (MDR021), bADH4 (MDR039), MDR044,
and MDR034 of yeast and bacterial alcohol dehydro-
genases, which all appear to bind NADP despite having
both the structural and catalytic Zn
2+ cofactor. Further
exceptions are the four families MDR018, YCJQ
(MDR052), BCHC of the bacterial chlorophyll synthesis
pathway (MDR057), and MDR069, which appear to pre-
fer NAD despite lacking the structural and catalytic Zn
2+
cofactors.
Species distribution
As shown in Figure 3, nearly 50% of the families are purely
bacterial, while only 14% are purely eukaryotic. None is
purely archaeal, but 17% of the families are represented in
Archaea. 10% of the families have representatives from all
kingdoms of life. Figure 4 shows more details on the spe-
cies distributions in the families (cf. Additional file 5: mdr-
distribution for exact figures). Still, most families are
dominated by prokaryotic species, although there are
some families with only plant sequences, and some with
sequences from other eukaryotes, for example MDR030
(dFAS) that consists of 28 sequences exclusively from the
invertebrate Dictyostelium discoideum. The seed
sequences for this HMM have 57.5% average identity.
Table 2 Correlation with known families
Family Number Size
ADH MDR001 931 ® 2217
CAD MDR010, MDR021 520 ® 661, 122
LTD MDR002 427 ® 774
TADH MDR016, MDR020, MDR029 330 ® 313, 128, 29
YHDH MDR012 295 ® 481
BPDH MDR011 229 ® 575
PDH MDR005 218 ® 328
TDH MDR014 215 ® 351
BurkDH MDR041 67 ® 114
MCAS, ACR MDR003 58, 25 ® 706
MECR MDR007, MDR037 49 ® 51, 20
VAT1 MDR008 39 ® 50
QOR MDR009 28 ® 22
DOIAD - -
QORL - -
RT4I - -
MDR families by name used in [1]. The CAD, TADH and MECR families are now
represented by two or three HMMs, and the MCAS and ACR families are now
incorporated into a single, much larger HMM. The DOIAD, QORL and RT4I1
families are not included in this study, because the amount of data available
on these families is insufficient to satisfy the minimum inclusion size
employed here.
Table 3 MDR forms with 2 Zn
2+ and no Zn
2+
0Z n
2+ 2Z n
2+
Archaea 5 28
Bacteria 3907 3395
Eukaryota 1041 1994
The numbers show number of MDR forms with no Zn
2+ and with 2 Zn
2+ in
each kingdom.
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Several MDR families are found to have a large number
of strictly conserved charged residues causing a large
net charge, which might indicate special binding proper-
ties or interaction with strongly charged substrates. The
BurkDH (MDR041) has a conserved net charge of -7,
while the YJDL (MDR054) and MDR070 both have a
conserved net charge of -5. Furthermore, BDH
(MDR033), MycDH (MDR086) and MDR038 also have
a conserved net charge of -5 (not including Zn
2+ ligand
glutamate residues). When including non-conserved
charges, the numbers become even more pronounced
for the first five families (average net charges -8.6, -7.2,
-11.1, -9.3 and -11.0, respectively) while only MDR038
has balancing non-conserved charges (average net
charge -3.6). All these six families can be expected to
have a positively charged substrate or interact with a
positively charged protein.
MDR037 is the only family found to have a large posi-
tive conserved net charge (+11). However these charges
are partially balanced by non-conserved positive charges,
leaving an average net charge of +8.7. This family could
consequently be expected to interact with negatively
charged substrates or proteins.
Differences in conservation between the catalytic and
coenzyme-binding domains
Looking at the number of conserved residues in the two
domains, measured as those attaining a cscore over 95%
(conservation score [22]), we find that some MDR
families show noticeable differences between the two
domains. A total of 14 MDR families were found with
more than twice as many conserved residues in one
domain compared to the other. There are 10 MDR
families with twice as many conserved residues in the
catalytic domain as in the coenzyme-binding (Table 4),
of which the most extreme cases are SDH (MDR005)
with a ratio of 3.5, and MDR013, MDR070, and
MDR080, all with a ratio of about 3.0. There are 4 MDR
families with twice as many conserved residues in the
coenzyme-binding domain as in the catalytic one (Table
4), of which the most extreme cases are VAT1
(MDR008) with 3.7 times difference and MDR035 with
2.25 times difference. These differences might reflect
differences in functional and/or structural properties.
Selected MDR families
The largest families and those with known functional
data of specific interest are described below.
The 10 largest families
Notably, all of the 10 largest MDR families have a high
degree of conservation in just one of the two domains
(five have over twofold conservation difference between
domains, Table 4).
1. MDR001 - ADH This family contains the classical
alcohol dehydrogenases, including human class I-V
alcohol dehydrogenase. Knowledge of this family has
grown from 931 members to 2217 since our last
review. It is currently the largest MDR family, and 116
of its members are found in the Swiss-Prot database.
59% of the members are eukaryotic and the average
amount of pairwise sequence identities is high but
variable (51% with 19 percent units standard devia-
tion). The members of this family have both the struc-
tural and catalytic Zn
2+, in agreement with their NAD
preference. The catalytic domain conservation is close
to twice (89%) that of the cofactor binding domain (17
versus 9 positions with cscores over 95%), indicating
that the catalytic machinery is well-conserved through
this enzyme family.
2. MDR002 - PTGR This family of NADP binding
prostaglandin reductases was previously described as
LTD and the number of known members has increased
from 427 to 774, with only 17 in the Swiss-Prot data-
base. While the family contains human prostaglandin
reductases 1 and 2, just over 2/3 of the members are
prokaryotic, and its average pairwise sequence identity is
only 42%. Most likely, the prokaryotic members have
other substrates since prostaglandins are only charac-
terised in verterbrates. Additionally, their conservation is
much higher in the cofactor binding domain than in the
catalytic domain (14 versus 7 positions with cscores
above 95%), further supporting that the substrate spec-
trum might vary between the members. This family
binds NADP and no Zn
2+, in agreement with the reduc-
tase function.
Figure 3 Venn diagram of kingdom representation in MDR
families. This diagram illustrates the presence of sequences from
the different kingdoms in the MDR families with number (and
proportion). Each circle encapsulates those families that have at
least one sequence from that corresponding kingdom. Blue (top)
denotes bacteria, red (left) denotes archaea, and green (right)
denotes eukarya. Intersections encapsulate families having at least
one member sequence from the corresponding kingdoms.
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acid synthases was previously described in part as two
separate subfamilies ACR and MCAS, but is now repre-
sented by a single HMM with 706 members instead of
the previously found 25 and 58 members, respectively.
Members are prokaryotic to 59% and the average
sequence identity is only 39%. Also in this family con-
servation is much higher in the cofactor binding domain
than in the catalytic domain (18 versus 8 positions with
cscores above 95%). The MDR domains in these
enzymes are annotated with enoyl reductase functional-
ity (by similarity) in Swiss-Prot. A reductase function
w o u l db ei na c c o r d a n c ew i t h their apparent NADP-
preference and lack of conserved Zn
2+ ligands.
4. MDR010 - CAD This family with cinnamyl alcohol
DHs, mannitol DHs and sinapyl DHs has both eukaryo-
tic and prokaryotic sequences. It was previously classi-
fied together with members from MDR021 as one
family [1], but is now represented by two disjoint
HMMs, where the latter one is smaller and covers
Figure 4 Species distribution in MDR families. The species distribution in the individual families is shown using a gradient from white to dark
blue (0% to 100% of the family). The columns represent the species groups A - archaea, B - bacteria, Pla - plants, Inv - invertebrates, Ver -
vertebrates, Mam - mammals, Rod - rodents, Pri - primates. The families are ordered according to the MDR family enumeration. The numerical
values underlying this figure are available in Additional file 5: mdr-distribution.
Table 4 Domain conservation ratios
Family Name Catalytic Coenzyme Ratio
MDR005 PDH 28 8 3.50
MDR080 bPDH 97 32 3.03
MDR070 30 10 3.00
MDR013 FDH 39 13 3.00
MDR047 47 20 2.35
MDR075 65 28 2.32
MDR032 bADH2 60 27 2.22
MDR065 41 19 2.16
MDR076 43 20 2.15
MDR004 QORX 17 8 2.13
MDR002 PTGR 7 14 0.50
MDR035 12 27 0.44
MDR003 FAS 8 18 0.44
MDR008 VAT1 10 37 0.27
This table shows the number of strictly conserved positions in the catalytic
and coenzyme binding domains, respectively. Furthermore, the ratio between
these numbers is calculated. The table only lists families with a ratio of 2 or
more and of 0.5 or less.
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Page 9 of 16mostly uncharacterised bacterial sequences (cf. Table 2).
MDR010 now has 661 known members, of which 32
can be found in the Swiss-Prot database. The catalytic
domain is more well-conserved than the cofactor bind-
ing domain (with 79% more positions in the former
domain attaining cscores over 95%). The members of
this family bind NAD and two Zn
2+.
5. MDR011 - bpQOR This family of mainly yeast and
bacterial quinone oxidoreductases was previously
described under the tentative name of BPDH (for Bac-
terial and Plant DHs). Now however, as the number of
known member sequences has grown from 229 to 575,
it also includes six sequences from Neurospora, Leish-
mania, Trypanosoma and Dictyostelium (cf. Additional
file 3: mdr-sequences). Still, only five of the sequences
are currently in Swiss-Prot.
6. MDR004 - QORX This family encompasses puta-
tive quinone oxidoreductases from many species, includ-
ing human quinone oxidoreductase PIG3 (tumour
protein p53 inducible protein 3), which is the only
Swiss-Prot sequence among its 486 members. The rate
of conservation is over twice as high in the catalytic
domain as in the cofactor binding domain. Substrate
specificity is still unknown. The PIG3 is strongly
expressed in neuronal cells of cerebral cortex and in
respiratory epithelial cells of nasopharynx [23].
7. MDR012 - YHDH This family was previously
described as a bacterial family under the name YHDH.
It has since grown from 295 to 481 members, including
a single eukaryotic sequence from the tunicate Oiko-
pleura dioica [UniProtKB:Q66S07].
8. MDR013 - FDH This family contains 375 members
including S-(hydroxymethyl)glutathione dehydrogenase
from Methylobacter marinus. 4 of its members are from
the Swiss-Prot database. It has an average pairwise
sequence identity around 47%, and much of the conser-
vation is seen in the catalytic domain, which has three
times as many positions with cscores over 95% than
does the cofactor binding domain (39 versus 13
positions).
9. MDR014 - TDH This family of threonine dehydro-
genases has been previously reviewed, for example in
[1], and currently has 351 members. They have con-
served ligands for both Zn
2+ cofactors, with the excep-
tion of 18 rhodobacteral and 6 other bacterial sequences
that do not have the sequence motif that binds the
structural Zn
2+.
10. MDR005 - PDH This family of sorbitol/xylitol
DHs and D-xylulose reductases now has 328 members.
Most of them bind 2 Zn
2+. However, in 113 of its mem-
bers the structural Zn
2+ binding loop is seemingly
retained, although the Zn
2+ ligands themselves are not
conserved. Notably, although this family contains both
dehydrogenases and reductases, structural Zn
2+ ligand
retention is not correlated with enzymatic function. For
example, the structural Zn
2+ ligands are present in sor-
bitol DH in fission yeast but not in baker’sy e a s t ,a n d
nor are they present in the latter’s D-xylulose reductase.
Furthermore, 28 positions in the catalytic domain
attain a cscore over 95%, which is 3.5 times the number
of such positions in the cofactor binding domain, indi-
cating evolutionary constraints on the catalytic residues.
Other families of interest MDR009 - vertQOR - is a
family dominated by quinone oxidoreductases and zeta-
crystallins from vertebrates, where the single non-eukar-
yotic sequence is from the bacterium Geobacter uraniir-
educens strain Rf4. It thus contains both enzymes and
structural proteins of the lens, which are recruited to
that function [24]. The family also includes one lancelet
form from Branchiostoma floridae [UniProtKB:
B6NHZ5] which was deleted in UniProtKB release 15.8
since the corresponding gene was not present in the lat-
est assembly of the genome. However, BLAST searches
against the UniProtKB and NCBI nr [25] databases
reveal that the most similar known sequence is from
platypus and shares only 60% identities with this deleted
form. The most similar non-vertebrate form is from
Monosiga brevicollis (a choanoflagellate) at 53% identi-
ties, and is superseded by 33 more similar vertebrate
sequences. It is therefore possible that this deleted lan-
celet form is not an artifact originating from a contami-
nating sequence, but may reappear in a later release of
the Branchiostoma floridae genome.
In the MDR019 family, eight yeast sequences of the
136 members seem to bind NADP instead of NAD.
Four of these sequences are from species having two
forms of this protein, of which one has NAD-typical
ligands and the other NADP-typical ones. The MDR023
family of ADHs from eukaryotic parasites as well as
thermophiles and other prokarya consists of two sub-
groups, one apparently using NADP as cofactor, the
other NAD. This difference does not appear to stem
from species multiplicity, as all sequences from any sin-
gle species exhibit the same cofactor binding motifs. A
small subset of four sequences show intermediate
properties.
The MDR020 (yADH) family contains tetrameric
ADHs from various yeasts, and also two forms from
Caenorhabditis elegans and one from Caenorhabditis
briggsae.
MDR022 (giFDH) contains glutathione-independent for-
maldehyde dehydrogenases from bacteria and yeast.
Family MDR030 (dFAS) has 28 members, all uncharac-
terised polyketide synthases from the slime mold Dictyos-
telium discoideum. Yet the average pairwise sequence
identity within the family is merely 57.5%. The MDR033
family consists of yeast (R,R)-butanediol dehydrogenases.
Here, 10 of 23 members have a glutamate to glutamine
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2+ ligand, which is
located in the first transdomain alpha helix. This substitu-
tion should preclude binding of the catalytic Zn
2+.H o w -
ever, the representative from Saccharomyces cerevisiae
[Swiss-Prot:P39713] is annotated as having the catalytic
Zn
2+, despite having only two ligands. However, all of
these 10 sequences come from species that have two
forms of this protein, and where the sibling sequences
have an intact third ligand for the catalytic Zn
2+. Further-
more, this family has an unusual insertion in the structural
Zn
2+ loop, between the first and second Zn
2+ ligands. The
length of this insertion seems to vary between members.
Also, as noted above, this family has a significant con-
served net charge of -5, or -8.6 when including non-con-
served charges (excluding Zn
2+ ligand glutamate), and
could therefore be expected to have positively charged
substrates or interaction partners.
In the MDR047 family of mainly bacterial starvation-
sensing oxidoreductases, 10 out of 72 members have
lost the ligands for the structural Zn
2+ cofactor through
a deletion precisely at the binding motif in the Zn
2+
binding loop. The catalytic domain has a higher degree
of conservation with 47 positions (excluding structural
Zn
2+ ligands) attaining a cscore over 95%, which is 2.35
times the number of such positions in the cofactor bind-
ing domain.
The members of the bacterial family MDR058 seem to
have ligands for the structural Zn
2+ cofactor, but
remarkably not for the catalytic Zn
2+ cofactor. The
members also have a conserved proline-rich motif near
the N-terminus, the most pronounced being PPPPPPGP
at position 18 in a sequence from Aurantimonas sp.
SI85-9A1 [UniProtKB:Q1YMF6]. Also the bacterial
family MDR083 presents the uncommon feature of hav-
ing ligands for the structural but not the catalytic Zn
2+.
Only 28 out of 40 members of the bBDH (MDR061)
family of bacterial 2,3-butanediol dehydrogenases have
ligands for the structural Zn
2+ cofactor. The remaining 12
still have a loop that is four residues shorter than its Zn
2+
binding counterpart. Similarly, in the family MDR077,
only 18 out of 28 members have ligands for the structural
Zn
2+ cofactor. The remaining 10 have seemingly lost the
Zn
2+ binding motif though consecutive substitutions, as
the degree of similarity to their Zn
2+ binding siblings is
still high in all other positions in the loop.
The MDR069 family is unusual in that it appears to
bind NADP despite having both the structural and cata-
lytic Zn
2+ cofactor. The conservation is low in the C-
terminal part of the catalytic domain, and the usually
well-conserved positive charge near the terminus is
absent. There is a highly positive conserved motif near
the NAD-binding VGV motif in 1PL8, as represented by
RKRGR in a Ralstonia solanacearum sequence [Uni-
ProtKB:A3RXV2].
The family MDR070 has an unusual, poorly conserved
region of variable length, close to the positive NADP
ligand 24 residues C-terminally of the glycine-rich
NADP binding motif (GxGxxG). As an effect, the num-
ber of positions attaining cscores over 95% in the cataly-
tic domain is threefold that of the cofactor binding
domain, with only 10 such positions. Furthermore, pro-
teins of this family have a conserved net charge of -5,
and may thus have have positively charged substrates or
interaction partners.
The algorithm
Searching UniProtKB we find sequences for 15136 MDR
domain pairs in 14996 proteins. Clustering sequences
with more than 40% pairwise identities leaves 1032 clus-
ters, where known families such as ADH, PDH and
PTGR are uniquely represented. 146 of these clusters
consist of more than 20 sequences, and were used for
protein family HMM generation, making a grand total
of 10193 sequences.
Some proteins, mainly polyketide synthases and type I
fatty acid synthases like [UniProtKB:Q5CQX7] and
[UniProtKB:O96554] from Cryptosporidium parvum,
contained several MDR domain pairs that were suffi-
ciently divergent to fall into separate clusters under the
chosen clustering rule. No special regard was given to
these clusters during HMM construction, refinement or
inclusion control, however all of them eventually con-
verged on (subsets of) the same evolutionary group,
namely MDR003 - FAS.
After 4 reiterations all HMM refinements using inclu-
sion control strategy II were stable (our favoured strat-
egy, see below). After resolving overlaps we obtained
stable HMMs for 86 MDR families. The corresponding
11579 seed sequences provide just over 76% coverage of
the MDR superfamily (cf Table 5). Two out of these 86
stable HMMs (MDR035 and MDR086) retained too few
Table 5 Characteristics for different inclusion control
strategies
Strategy Families Sequences Reiterations Subsets
I, exclusive 92 (15) 10401 6 22 {16}
II, intermediate 86 (2) 11579 4 34 {14}
III, inclusive 85 (2) 11657 2 36 {15}
Three different strategies for inclusion control were employed, affecting the
number of resulting HMMs as well as their composition and relations. Roman
numerals denote the different strategies, in increasing order of inclusiveness.
Parenthesised numbers show the number of HMMs that were not affixed with
the “reliable” qualifier, due to having too few non-spurious sequences in their
seed sets. Numbers in braces denote the number of families having such
subsets.
In strategy I, all seed sequences failing the leave-one-out check were
excluded. In strategy II, only seed sequences with domain scores lower than
noise level were excluded. Additionally, for a left-out seed sequence to be
excluded in strategy III, its domain score must fall below 90% of the lowest
domain score among the remaining seed sequences.
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sion control step (cf. Methods below). These HMMs
comprise a total of 42 seed sequences and are stable,
and were thus still kept (but explicitly annotated as
potentially less reliable). Past the first inclusion control
step, it was possible to classify all remaining HMMs as
reliable in all of the strategies.
34 of the refinement processes stabilised on distinct
subgroups to 14 of these 84 families, and these were
retained separately because of their potential utility for
subclassification. It should however be noted that this
work does not attempt to provide a comprehensive list-
ing of all MDR subfamilies, but these 86 HMMs are
rather presented as a means to aid automated
classification.
Inclusion control and overlap resolution
In order to ensure consistency in our refined HMMs we
evaluated three different leave-one-out validation strate-
gies for seed sequences (cf. Table 5). Unsurprisingly, the
most inclusive strategy (III) yielded the most numerous
and largest overlaps between seed sets, while exactly the
opposite was true for the most exclusive strategy (I).
However, for strategy III, the overlaps were generally tri-
vially resolvable, most often simply by raising the inclu-
sion threshold slightly for one of the participants, while
for strategy I some overlaps were only resolvable
through mergers and subsequent refinement reitera-
tions. As an example; in strategy I, one cluster of 1390
sequences was found to be a subset to MDR001 (1631
sequences) with the exception of 7 sequences which
were included late in the refinement process. A neigh-
bour joining dendrogram of the smaller cluster showed
that these sequences originated from separate subgroup-
ings, and although it was possible to exclude them from
the cluster by removing the 70 lowest scoring seed
sequences, these 7 sequences would be re-included in
the subsequent refinement step. Conversely, merging
the 7 sequences into the larger set yielded a HMM that
became divergent in the subsequent refinement step. In
the more inclusive strategies on the other hand, these
clusters had a clear subset relation, lending further
incentive to favour one of these strategies.
Strategy III ultimately proved to be the fastest, since it
required the fewest reiterations of refinement and inclu-
sion control before all HMMs were stable. The apparent
speed loss of the more inclusive strategies impacted by
the time consuming database searches during inclusion
control was more than compensated by the ease of over-
lap resolution and the lower number of refinement
reiterations required for convergence. The intermediate
strategy (II) was found to be an optimal compromise
between I and III, occupying the middle ground in these
aspects; it is reasonably fast and offers the ease of over-
lap resolution of strategy III. Another clear advantage of
strategy II is that it does not rely on user input beyond
initial HMM creation, but instead purely uses relations
in data to produce the resulting models.
One concern during the development of the refi-
nehmm algorithm was thati n c l u s i o no fp a r t i a l
sequences into the seed sets could lead to attenuation of
predictive power of the model, since this would intro-
duce a biased delete state preference near the N- and C-
termini of the model. To counteract this we attempted
to introduce a minimum model coverage requirement
for inclusion of new seed sequences, expressed as a per-
centage of the model length, and we evaluated the
thresholds 90%, 85%, 80% and 0%. Ultimately, the 0%
coverage limit proved to be sufficient, as the hmm_ls
HMM type itself provides sufficient penalisation of par-
tial sequences to ensure that they will not increasingly
dominate the refined seed sets.
Computation time and parallelisation
Since the individual refinement processes are indepen-
dent, this algorithm for HMM refinement is trivially
parallelisable. Furthermore, the output files and the var-
iant input files are small. The database files are the only
large files needed by the algorithm, and as these are
invariant, they can be cached on the compute resource.
These traits make refinehmm well suited for burst com-
puting on shared resources as well as distributed
resources such as Swegrid (the Swedish computational
grid). Indeed, all refinements and leave-one-out compar-
isons to UniProtKB were computed on Swegrid
resources using Biogrid runtime environments (bioinfor-
matics virtual organisation in the Nordic Data Grid
Facility) [26]. Internal leave-one-out comparisons were
fast enough to compute locally, rather than distributed.
The refinehmm algorithm uses version 2.3 of HMMER,
but is written so that a transition to HMMER 3.0 will
be straightforward once a stable release with glocal
alignment capabilities is available. As the HMMER data-
base search is by far the most time consuming step in
the refinehmm algorithm, we estimate that transitioning
will decrease the total computation time by at least an
order of magnitude, and quite possibly even more.
Validation
T h eH M M sw e r eb u i l ta n dr e f i n e da g a i n s tv e r s i o n1 4 . 8
of UniProtKB, and in order to evaluate the consistency
of the annotation of the 86 families defined in this
work, we investigated the annotation of all new MDR
sequences in new releases of Swiss-Prot up to version
15.10. We found 118 new matches against the PfamA
MDR HMMs, out of which 90 were upgrades from Uni-
ProtKB/TrEMBL sequences, and 28 were novel entries
in Swiss-Prot. Our models detected all of these new
sequences (except for 14 of the novel ones, see below)
and none of these had annotations that conflicted with
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Out of the 14 sequences that were not detected, 12
were annotated as probable polyketide synthases of Dic-
tyostelium discoideum, and would perhaps have been
expected to match MDR030 (dFAS). The remaining two
([UniProtKB:Q5AUY5] and [UniProtKB:O42909]) had
annotations relating the proteins to ADH-like enzymes,
but nothing more functionally specific. Since our models
professedly do not provide 100% coverage of the MDR
superfamily, it should be expected that some new MDR
sequences will not be classifiable through our current
library of HMMs. However as more sequence data on
MDRs is amassed, further HMMs may be developed
using our algorithm, improving the library and its cover-
age of the MDR superfamily even further.
Web site
In order to make our results directly useful also for
scientists outside the bioinformatics area, we have devel-
oped a web site that presents our findings in an easily
navigable point-and-click interface. The web site enables
users to search and display detailed information about
the MDR families, using textual and numeric queries
against many of their characterised properties. It also
permits online hmmpfam queries against our library of
MDR HMMs, making it possible to submit a novel
MDR sequence and have it instantly analysed and classi-
fied. The web site also provides direct downloads for the
underlying MDR HMM library as well as the web site
database files, providing the opportunity for advanced
users to do more advanced queries offline.
The web site is available at http://mdr-enzymes.org/.
Conclusions
We have developed an algorithm for HMM refinement
that produces stable and reliable HMMs. We have used
this algorithm to subdivide a large and complex protein
superfamily into smaller units of homologous members,
yielding HMMs for 86 MDR families and 32 distinct
subsets to 14 of the families. These HMMs are suitable
for reliable automated classification of new sequence
data. The generated families correlate well with the
more empirically chosen family definitions that were
employed in our recent review, lending further evidence
to the reliability of the algorithm.
Furthermore, 1/4 of the MDR members have only few
(or none) close homologues, forming only small families,
presently each with less than 20 members. Thus, the
MDR superfamily shows a complexity and spread as
previously described for the SDR superfamily.
We analysed conservation in these 86 families as well
as characterised their NAD(P) and Zn
2+ cofactor prefer-
ence based on mappings to their closest available struc-
tures. It was found that MDR families with 2 Zn
2+ in
general have NAD preference, while those families with
no Zn
2+ in general had preponderance for NADP.
We have also developed a web site http://mdr-
enzymes.org where users can search and display detailed
information on the families defined and characterised. It
is also possible to scan putative new MDR sequences
and have them instantly analysed and classified. These
features make our findings directly available and useful
also for non-bioinformaticians.
The implementation and support scripts for running
the algorithm on computer clusters are available as
open source software, and the database files underlying
the web site are freely downloadable.
Methods
Initial HMM creation
MDR domains were extracted from UniProtKB 14.8
using hmmsearch from the HMMER package [27] with
two hmm_ls query HMMs from PfamA; ADH_N
[PfamA:PF08240] and ADH_zinc_N [PfamA:PF00107],
corresponding to the N-terminal catalytic GroES-like
domain and the C-terminal Rossmann fold cofactor
binding domain. The extracted domains included linker
regions between closely located
ADH_N/ADH_zinc_N match pairs, and singlet
matches were expanded to include potentially missed
HMM partner matches, simply by moving the corre-
sponding inclusion boundary outwards by the expected
length of the linker and absent domain plus a small
error margin. Partial sequences shorter than 250 resi-
dues were removed before clustering domains with
sequence identity higher than 40% using cd-hit [28].
Clusters containing more than 20 sequences were
aligned using mafft-L-INS-i [29] and used as seed sets
for creating hmm_ls HMMs using hmmbuild from the
HMMER package.
HMM refinement
The refinehmm algorithm is initiated with an HMM
which is iteratively refined through progressive database
searches and subsequent adaption of the model. In each
iteration, all domain matches scoring higher than the
worst scoring seed domain are extracted and included
in the seed for the next iteration, and when the seed is
stable the process is terminated. Refinehmm uses
hmmalign and hmmbuild from the HMMER package to
build the HMMs; hmmalign to align the seed set for the
next iteration against the current HMM, and hmmbuild
to produce hmm_ls HMMs from the resulting align-
ment. The algorithm is implemented in python.
HMMs refinements gathering more than 3000 seed
sequences were classed as divergent and aborted, and
these were rerun after manual curation of the initial
seed sets. For this curation, the HMMs were aligned
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the lowest scoring sequences were progressively
removed until HMM refinement became convergent.
HMMs that became divergent during later refinement
reiterations (see below) were treated identically; by cura-
tion of their corresponding initial seed sets and restart-
ing the refinement process from scratch. Finally, the
maximum resulting domain score was recorded for each
seed sequence, and the minimum of these was recorded
as gathering- and trusted cutoffs for each HMM. Noise
cutoff was recorded as 0.1 less.
Inclusion control
All refined (converged) HMMs were subjected to leave-
one-out stability checks in order to remove potentially
erroneously included seed sequences. Here, the HMM
was repetitively rebuilt, leaving out one seed sequence at
a time, and in a subsequent database search the domain
score of the seed sequence in question and its relation to
other domain hits were noted. Three removal strategies
were employed (cf. Table 5). In the most exclusive strat-
egy (I), left-out seed sequences were classified as spurious
if they received a lower domain score than the remaining
seed sequences. In the intermediate strategy (II), the
domain score for the left-out sequence must also be
exceeded by at least one non-seed sequence in order to
be classified as spurious, indicative of a membership
strength below the noise level. Additionally, for a seed
sequence to be classified as spurious in the most inclusive
strategy (III), its assigned domain score must fall below
90% of the lowest domain score among the remaining
seed sequences. HMMs having no spurious seed
sequences were classified as stable and reliable. Sets with
less than 20 non-spurious sequences (MDR035 and
MDR086) were classified as stable but potentially less
reliable, indicated by an ‘x’ postfix to the HMM name
and with an explicit warning in the HMMs description
field. All spurious sequences were then removed from
the non-stable seed sets, which were then realigned using
mafft-L-INS-i and used to build new hmm_ls HMMs.
These resulting HMMs were then re-injected into the
refinement process, starting with refinement with refi-
nehmm. Past the first inclusion control step it was possi-
ble to classify all remaining refined HMMs as reliable.
For strategy I, inclusion control comparisons were
done internally, e.g. against the original seed sets. For
t h em o r ei n c l u s i v es t r a t e g i e s ,o n l yt h o s ec o m p a r i s o n s
failing the inclusion criteria for strategy I were re-evalu-
ated against the UniProtKB database, greatly reducing
the computation time.
Model overlaps
Overlaps between stable HMMs were resolved in a
number of ways. For true subset relations - the most
common type of overlap - the superset was kept and the
subsets were set aside, giving special note to disjoint
subsets given their utility for discrimination between
subfamilies.
In partially overlapping sets, the inconsistent domains
were typically assigned very low domain scores by one
of the HMMs, permitting resolution of the overlap by
simply raising the score threshold for the corresponding
HMM slightly so that the inconsistent domains - along
with a handful similarly low-scoring domains - became
excluded. The corresponding seed sets were then edited
to reflect this. The rebuilt HMMs were without excep-
tion stable and consistent, which was verified by
refinehmm.
The few overlaps where the inconsistent domains
were assigned high domain scores were instead
resolved through mergers, in an effort to find a com-
mon evolutionary supergroup. In these mergers, the
non-overlapping domains from the smaller seed set
were added to the larger seed set, which was then rea-
ligned using mafft-L-INS-i and used to build an
expanded HMM. The merged HMMs were subjected
to refinement using refinehmm in order to ensure sta-
bility and consistency.
Subfamily informatics
Species distribution in each family was determined using
t h eN C B IT a x o n o m yd a t a b a s e[ 3 0 , 3 1 ]e x t e n d e dw i t h
archaea/bacteria classifications from UniProtKB. One
sequence from MDR001 and three sequences from
MDR012 belonging to the NCBI Taxonomy “Unclassi-
fied” division were disregarded for the species analyses.
Sequence identity was calculated as the number of iden-
tical residues found by pairwise BLAST [32] divided by
the length of the longer sequence. Dendrograms were
computed using the ClustalW neighbour joining algo-
rithm [33] applied to mafft-L-INS-i MSAs, and were
visualised using Dendroscope [34].
For each family full length sequences were extracted
(only the two MDR domains in case of multidomain
sequences like the fatty acid synthases), excluding
sequences shorter than 270 residues. The sequence sets
were redundancy reduced to less than 90% sequence
identities using cd-hit, and multiply aligned using mafft-
L-INS-i. The best representative structure was deter-
mined for each family through blast searches against a
database of all MDR structures in PDB [35]. In those
cases where the best match yielded an ill-fitting struc-
ture due to a highly similar but atypical sequence, we
also employed a voting approach that selected the struc-
ture that was the best match for the most sequences in
the family. The structure sequences were added to the
preexisting family MSAs using mafft. Presence of cofac-
tors such as NAD(P), and catalytic and structural Zn
2+,
Hedlund et al. BMC Bioinformatics 2010, 11:534
http://www.biomedcentral.com/1471-2105/11/534
Page 14 of 16was assessed through ocular inspection of conserved
sequence motifs and conserved ligands in structure. All
mapping of motifs and conservation, as well as visualisa-
tion of alignments, were made using the msaview multi-
ple sequence alignment analysis package (Hedlund, to
be published).
The homogeneity of the families was assessed through
comparison of sequence descriptions, giving priority to
annotations from the Swiss-Prot database and ignoring
descriptions containing qualifiers such as “putative”,
“uncharacterized”, “hypothetical” and “predicted”.
Availability and requirements
The implementation and support scripts for running the
algorithm on computer clusters are available as open
source software (cf. below, and also Additional file 6:
refinehmm and Additional file 7: grid_workdir).
￿ Project name: RefineHMM
￿ Project home page: http://sourceforge.net/projects/
refinehmm
￿ Operating systems: Platform independent
￿ Programming language: Python 2.x (x ≥ 5)
￿ Other requirements: HMMER 2.x (x ≥ 3)
￿ License: MIT
￿ Any restrictions to use by non-academics: License
required.
Additional material
Additional file 1: Further properties of MDR families. This table
extends Table 1 with several additional columns, showing further
properties derived during our characterisation of the 86 MDR families;
Description (sequence description of one representative seed sequence),
Cat 95% (number of positions in the catalytic domain that attain a cscore
above 95%), Cat 100% (number of positions in the catalytic domain that
attain a cscore of 100%), Cat KR-ED (number of conserved positive
charges minus number of conserved negative charges in the catalytic
domain; values < -3 or > +1 indicated in yellow), CE 95% (as Cat 95%,
but for the coenzyme binding domain), CE 100% (as Cat 100%, but for
the coenzyme binding domain), CE KR-ED (as Cat KR-ED, but for the
coenzyme binding domain), Cat/CE 95% (Cat 95% divided by CE 95%;
values ≤ 0.5 indicated in orange, ≥ 2 in blue), Structure (ID of the PDB
structure found to be most similar to any of the sequences in the
family), Most similar (ID of the seed sequence most similar to Structure),
Zn1cons (presence of catalytic Zn
2+ ligands), Zn1charge (sum of charges
of catalytic Zn
2+ ligands, in the range [-3,0]), Zn2cons (presence of
structural Zn
2+ ligands), Zn1charge (sum of charges of structural Zn
2+
ligands, in the range [-4,0]), Normcharge (sum of conserved charges,
excluding conserved Zn
2+ ligand charges; values < -4 or > 3 indicated in
yellow), Zn (number of Zn
2+ cofactors; dual binders indicated in blue,
single binders in light blue, and non-homogeneous families are indicated
in orange), Zn2 not Zn1 (having structural but not catalytic Zn
2+; orange
if nonzero), 2Zn not NAD (having both Zn
2+ ligands without binding
NAD; orange if nonzero), 0Zn not NADP (having no Zn
2+ ligands without
binding NADP; orange if nonzero), NAD (binds NAD), and NADP (binds
NADP).
Additional file 2: MDR HMM library. A database containing the final
HMMs for all 86 MDR families described in this work. Compatible with
hmmpfam from the HMMER package [27].
Additional file 3: MDR HMM Sequence data. Sequence data on the 86
MDR families. The *.seed files contain the sequences that were used to
build the HMMs, and *.fasta files contain the corresponding full-length
protein sequences. The *.mafft files contain mafft-L-INS-i MSAs for full-
length sequences (or member domain pairs in case of multidomain
proteins) after redundancy reduction to less than 90% pairwise sequence
identities.
Additional file 4: MDR family alignment figures. Illustrations showing
the mafft MSAs from Additional file 3: mdr-sequences. Red sequence
identifiers denote sequences from UniProtKB/TrEMBL, while blue
correspond to sequences from Swiss-Prot. The position cscores are
shown in a bar plot under the MSA. Positions that contain gaps in over
90% of the sequences have been removed from the alignment in order
to increase readability.
Additional file 5: Species distribution in MDR families. The numerical
data underlying Figure 4 as a fixed width plain text text file of n(n/N)
values where n denotes the number of seed sequences from the
evolutionary group in question and N is the size of the corresponding
seed set.
Additional file 6: Refinehmm source code. Python source code for the
HMM refinement algorithm described in this work. Requires HMMER 2.x
(x ≥ 3) and python 2.y (y ≥ 5) to run. See enclosed README.TXT for
information on installation and usage.
Additional file 7: Refinehmm support script source code. A collection
of utilities that facilitate running refinehmm on a computational resource,
primarily NDGF Biogrid. Requires Python 2.y (y ≥ 5) and a bash shell to
run. See enclosed README.TXT for information on installation and usage.
Abbreviations
ADH: alcohol dehydrogenase; DH: dehydrogenase; HMM: hidden Markov
model; MDR: medium-chain dehydrogenase/reductase; MSA: multiple
sequence alignment; SDR: short-chain dehydrogenase/reductase; Zn
2+: zinc
ion.
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